Home
About
Overview
Sharing Data
ORCID
Help
History (17)
From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
Tailoring tyrosine kinase inhibitors to fit the lung cancer genome.
Haplotype analysis of APOE intragenic SNPs.
The enduring quest for effective and accessible women's sexual and reproductive healthcare.
Reviewing concomitant medications for participants in oncology clinical trials.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reviewing concomitant medications for participants in oncology clinical trials.
McGahey KE, Weiss GJ. Reviewing concomitant medications for participants in oncology clinical trials. Am J Health Syst Pharm. 2017 Apr 15; 74(8):580-586.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Clinical Trials as Topic
Drug Interactions
Drugs, Investigational
Humans
Neoplasms
Practice Guidelines as Topic
authors with profiles
Glen Weiss MD, MBA